In the last trading session, 4.33 million Conduit Pharmaceuticals Inc (NASDAQ:CDT) shares changed hands as the company’s beta touched 2.20. With the company’s per share price at $0.10 changed hands at -$0.01 or -7.83% during last session, the market valuation stood at $11.39M. CDT’s last price was a discount, traded about -7730.0% off its 52-week high of $7.83. The share price had its 52-week low at $0.08, which suggests the last value was 20.0% up since then. When we look at Conduit Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 7.53 million shares, with the 3-month average coming to 15.03 million.
Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information
Instantly CDT was in red as seen at the end of in last trading. With action 1.52%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -97.80%, with the 5-day performance at 1.52% in the green. However, in the 30-day time frame, Conduit Pharmaceuticals Inc (NASDAQ:CDT) is -14.09% down. Looking at the short shares, we see there were 1.45 million shares sold at short interest cover period of 0.25 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 49.12% of Conduit Pharmaceuticals Inc shares while 3.01% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 5.91%.
